Practice question

Answer the question and get instant feedback.

MediumRheumatologyMethotrexate Monitoringukmlamrcgp aktpanemrcp part 1prescribing safety assessment

A 62-year-old woman with rheumatoid arthritis, well-controlled on methotrexate 15mg weekly and folic acid 5mg weekly (taken on a different day), attends for routine blood monitoring. Which blood test abnormality would be the *most* concerning potential side effect of methotrexate requiring immediate action (e.g., withholding)?

Educational content. Not a substitute for clinical judgement or local policy.